Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 133

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 133
---
 the assistance of brokerage houses, fiduciaries, custodians and other third parties in soliciting proxies. We will, upon request, reimburse brokerage firms and other third parties for their reasonable expenses incurred for forwarding solicitation material to beneficial holders of our common stock. We have also retained Alliance Advisors, a proxy solicitation firm, to assist in the solicitation of proxies, as need be, for a fee of $16,000, plus reimbursement of expenses. All solicitation expenses, including costs of preparing, assembling and mailing proxy materials, will be borne by us.

#### Websites
Information on or connected to our website (or the website of any third party) referenced in this Proxy Statement is in addition to and not a part of or incorporated by reference into this Proxy Statement. Such additional information speaks as of the date thereof and is not intended to be confirmed or updated by reference herein. The Company disclaims any liability or responsibility for or endorsement of the information on or connected to the website of a third party.

#### 2025 Proxy Statement113

#### Annex A
<div align='center'>Reconciliations of Non-GAAP Financial Measures Used in Incentive Compensation Plans and Programs (1)</div>

The following is a reconciliation of net sales growth prepared in accordance with generally accepted accounting principles in the United States (GAAP) to Organic Net Sales Growth as used in our 2024 Organic Net Sales Growth Performance Share Program (2024 ONSG PSP).

|                                            |     |         |      | 2024 |
| As reported net sales growth vs. 2023      |     |         | 17.6 |    % |
| Impact of foreign currency fluctuations    
 Impact of recent acquisitions/divestitures |     | 0.9 %   
 (2.1) % |      |      |
| Organic Net Sales Growth vs. 2023          |     |         | 16.4 |    % |

The following is a reconciliation of net sales prepared in accordance with GAAP to Adjusted Net Sales as used in our 2024, 2023, 2022, 2021 and 2020 Annual Bonus Plans:

| (in millions)                                        |     |   |        | 2024 |     |   |        | 2023 |     |   |        | 2022 |     |   |        | 2021 | 2020 |       |
|:-----------------------------------------------------|:----|:--|-------:|-----:|:----|